Home » First-in-Human Trials Guideline Focuses on Lowering, Managing Risks
First-in-Human Trials Guideline Focuses on Lowering, Managing Risks
August 15, 2007
A final guideline issued last month by the European Medicines Agency (EMEA) gives drug manufacturers a range of strategies for reducing and managing the potential risks to volunteers in first-in-human clinical trials.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor